Dear Gov. Brown, What's a Vagina Worth? I Support Women's Rights

(800) 511-3838 |

Monsanto’s Roundup Tied to Cancer

Monsanto intentionally suppressed information from the public. Get the facts.

What They Knew

The FDA approved Abilify in 2002. In May 2015, the FDA published a safety announcement stating that Abilify is linked to several “compulsive or uncontrollable urges” including compulsive gambling. On May 4, 2016, the FDA required that Abilify have a new warning label listing the potential for these hazardous behaviors.

When They Knew It

In the early stages of testing Abilify, doctors recognized that hypersexuality, a form of compulsive behavior, was an adverse effect of patients who took this medication. However, the warning label never alerted patients to this potential problem. Additionally disconcerting is that in October 2012, the European Medicines Agency (EMA) – which is like our FDA – added a warning label to Abilify to reflect the potential for pathological gambling. Even Canada added this warning to Abilify labels before the United States in November 2015.

Countless patients around the world have been reporting that after taking Abilify, they had an uncontrollable urge to gamble.

  • In March 2010, a 64-year-old women who was taking 15 mg of Abilify reported that she couldn’t stop gambling or over-eating.
  • In December 2010, a study was published that found a link between how mutant HTR2B (a receptor that Abilify effects) increases impulsive behaviors.
  • In January 2016, Nicholas T. Meyer filed a lawsuit against Bristol-Myers Squibb which caused him, “harmful compulsive behaviors including compulsive gambling [and resulted] in substantial, financial, mental, and physical damages.”

What Can You Do

If you took Abilify and had a gambling problem after taking this medication, you may be able to receive compensation. You and your family may have experienced stress and suffering as a result of this destructive compulsive behavior and have accumulated bills or were forced to take time off of work because of it. There was a minimum of 3 ½ years where Bristol-Myers Squibb knew that their drug could cause uncontrollable urges, and yet they never warned doctors or patients of these horrible adverse effects. Contact us today to see if you qualify to make a claim.

Roundup Warnings In The News

BREAKING (3/23/19): Weed killer Roundup increases risk of cancer by 40 percent, UW study finds

Exposure to chemicals in weed killer Roundup increases the risk of some cancers by more than 40 percent, according to a University of Washington study.

Researchers found that the link between the most widely used herbicide glyphosate and developing Non-Hodgkin Lymphoma is stronger than previously reported.

They examined studies between 2001 and 2018, finding that the risk of developing that type of cancer increases by 41 percent.

Read Full Article

BREAKING (3/19/19): Second U.S. jury finds Bayer's Roundup caused cancer

A U.S. jury on Tuesday found Bayer AG’s glyphosate-based Roundup weed killer caused cancer, a blow to the company eight months after another jury issued a $289 million (217.8 million pounds) verdict over similar claims in a different case.

Tuesday’s unanimous jury decision in San Francisco federal court, which came after five days of deliberation, was not a finding of Bayer’s liability for the cancer of plaintiff Edwin Hardeman. Liability and damages will be decided by the same jury in a second trial phase beginning on Wednesday.

Read Full Article

 

BREAKING (2/27/19): Weedkiller ‘Raises Risk of Non-Hodgkin Lymphoma by 41%’

A broad new scientific analysis of the cancer-causing potential of glyphosate herbicides, the most widely used weedkilling products in the world, has found that people with high exposures to the popular pesticides have a 41% increased risk of developing a type of cancer called non-Hodgkin lymphoma.

The evidence “supports a compelling link” between exposures to glyphosate-based herbicides and increased risk for non-Hodgkin lymphoma (NHL), the authors concluded, though they said the specific numerical risk estimates should be interpreted with caution.

Read Full Article

 

8/30/18: How safe is Monsanto's Roundup? Jury verdict gives cause for pause

It’s been three weeks since a San Francisco jury found that exposure to Monsanto’s Roundup herbicides contributed to former school groundskeeper Dewayne” Lee” Johnson’s terminal cancer and awarded a stunning $289 million in damages to the 46-year-­old father.

During that time, we’ve seen repeated assertions from the pesticide giant and its allies that, in fact, the jury was wrong and the weed killer of choice for millions.

Read Full Article

 

8/10/18: Monsanto Owes $289M In Landmark Roundup Cancer Trial

 

A California jury held Friday that Monsanto’s Roundup and Ranger Pro herbicides contributed to a school groundskeeper’s lymphoma and slapped the company with a combined $289 million in compensatory and punitive damages in a landmark suit against the agricultural giant, which has denied links between its herbicides and cancer for decades.

After three days of deliberating, a unanimous 12-member jury found that Monsanto’s herbicides were unsafe and were a substantial factor in causing harm to plaintiff DeWayne “Lee” Johnson. The jury also found that Monsanto had failed to adequately warn customers of the risks associated with its Roundup and stronger Ranger Pro products, and that the company acted with malice or
oppression.

Read Full Article

8/2/18: New York Toxicologist Proves Roundup Causes Cancer in Current San Francisco Trial

 

In the current trial involving Monsanto’s Roundup versus former groundskeeper DeWayne Johnson, evidence was presented that glyphosate shows a strong link to cancer. Hopefully these findings will finally hold Monsanto accountable for putting the health of countless people at risk.

Johnson was a groundskeeper for the school district in Benicia, a suburb near San Francisco, and would regularly spray Roundup as part of his job averaging about 150 gallons of Roundup 20 to 30 times a year. During the four years that he was employed in this position, he started to develop rashes and lesions. Soon after, he was diagnosed with non-Hodgkin lymphoma, a specific type of blood cancer.

Read Full Article

 

7/25/18: Monsanto Trial: Toxicologist Explains to Jury How Monsanto Colluded With EPA

 

 

The plaintiff, Dewayne Johnson, a 46-year-old former school groundskeeper who was diagnosed with non-Hodgkin lymphoma four years ago, claims Monsanto hid evidence that the active ingredient in its Roundup herbicide, glyphosate, caused his cancer.

This is the first case to go to trial among hundreds of lawsuits alleging Roundup caused non-Hodgkin lymphoma. The trial is expected to last about a month. (Read recap).

Read Full Article

 

 

6/18/18: Roundup Trial to Start This Week

Monsanto, makers of the controversial weedkiller Roundup, is once again centerstage as they struggle to prove the safety of their product in a bellwether-like trial being held in California Superior Court, San Francisco.

This case centers around Lee Johnson, a 46-year old groundskeeper who worked for the school district of Benicia (located in the San Francisco Bay Area). His job required him to mix hundreds of gallons of Roundup and by July 2014, just two years after starting the job, Johnson was diagnosed with a type of non-Hodgkin’s lymphoma. Non-Hodgkin’s lymphoma is a cancer that has been linked to the use of glyphosate, the main ingredient found in Roundup. Even after completing chemotherapy and other treatments, Johnson recently received the painful news from his oncologist that he has only six months to live.

Read Full Article

6/27/17: California Is Adding a Chemical Found in Monsanto's Roundup Weed Killer to Its List of Cancer-Causing Agents

 

 

Glyphosate, an herbicide and the active ingredient in Monsanto Co’s popular Roundup weed killer, will be added to California’s list of chemicals known to cause cancer effective July 7, the state’s Office of Environmental Health Hazard Assessment (OEHHA) said on Monday.

Monsanto vowed to continue its legal fight against the designation, required under a state law known as Proposition 65, and called the decision “unwarranted on the basis of science and the law.”

Read Full Article

7/13/17: Does the World’s Top Weed Killer Cause Cancer? Trump’s EPA Will Decide

Far from settling the matter, eight of the 15 experts expressed significant concerns about the EPA’s benign view of glyphosate, and three more expressed concerns about the data. Their skepticism also raised, again, questions about the independence of the Office of Pesticide Programs, which has the final say on permitting pesticides. The office relies on pesticide manufacturers for the data it uses in making health decisions—and got almost 30 percent of its operating budget from the industry last year.

Read Full Article

Damaging Effects of Roundup (and Its Active Ingredient Glyphosate)

Glyphosate accumulates in the food portion of Roundup Ready plants, for which allowable residue herbicide thresholds have been increased by up to 200-fold. Glyphosate exposure has been linked to sterility, hormone
disruption, abnormal and lower sperm counts, miscarriages, damaged human embryonic and placental cells, placental cell death, birth defects, and cancer. It is also toxic and lethal to amphibians.

Read Full Article

Filed Roundup Complaints & Damages

7/19/17: Poulson et al v. Monsanto Company

The IARC Working Group classified glyphosate as a Group 2A herbicide, which means that it is probably carcinogenic to humans. The IARC Working Group concluded that the cancers most associated with glyphosate exposure are non-Hodgkin lymphoma and other haematopoietic cancers, including lymphocytic lymphoma/chronic lymphocytic leukemia, B-cell lymphoma, and multiple myeloma.

Read Full Case

6/20/17: Blitz, Thomas et al v. Monsanto Company et al

Monsanto labels, advertises, and promotes their retail Roundup® products, including but not limited to their Roundup® “Garden Weeds” Weed & Grass Killer products(“Roundup” or “Roundup Products”),1 with the false statement that Roundup’s active ingredient, glyphosate, targets an enzyme that is not found “in people or pets.”

However, this claim is false, misleading, and deceptive, as the enzyme that glyphosate targets is found in people and pets—specifically, in beneficial gut bacteria critical to their health and wellbeing, including their immune system, digestion, allergies, metabolism, and even their brain function.

Read Full Case

11/7/16: Randall Dean Seidl v. Monsanto Company

For nearly 40 years, farms across the world have used Roundup® without knowing of the dangers its use poses. That is because when Monsanto first introduced Roundup®, it touted glyphosate as a technological breakthrough: it could kill almost every weed without causing harm either to people or to the environment. Of course, history has shown that not to be true. According to the WHO, the main chemical ingredient of Roundup®—glyphosate—is a probable cause of cancer. Monsanto assured the public that Roundup® was harmless. In order to prove this, Monsanto has championed falsified data and has attacked legitimate studies that revealed Roundup®’s dangers. Monsanto has led a prolonged campaign of misinformation to convince government agencies, farmers and the general population that Roundup® is safe.

Read Full Case

9/8/16: Harris et al v. Monsanto Company et al

This is an action for damages suffered by Plaintiffs as a direct and proximate result of Defendants’ negligent and wrongful conduct in connection with the design, development, manufacture, testing, packaging, promoting, marketing, advertising, distribution, labeling, and/or sale of the herbicide Roundup, containing the active ingredient glyphosate.

Plaintiffs maintain that Roundup and/or glyphosate is defective, dangerous to human health, unfit and unsuitable to be marketed and sold in commerce, and lacked proper warnings and directions as to the dangers associated with its use. Plaintiffs’ injuries were avoidable.

Read Full Case

Monsanto’s Roundup Settlement Information

Featured Roundup Health Resources

Cheers! Roundup Now Found in Beer and Wine

Several studies have revealed that Roundup is contaminating a large portion of American made wine and beer. Is this something to worry about or just a bunch of hype? Find out here.

6 Unbelievable Facts About Roundup

Many people are wondering if the hype surrounding Roundup’s dangers are justified. Is Roundup a needed herbicide or a danger to consumers? Find out now.

Featured Roundup Health Resources

Cheers! Roundup Now Found in Beer and Wine

Several studies have revealed that Roundup is contaminating a large portion of American made wine and beer. Is this something to worry about or just a bunch of hype? Find out here.

6 Unbelievable Facts About Roundup

Many people are wondering if the hype surrounding Roundup’s dangers are justified. Is Roundup a needed herbicide or a danger to consumers? Find out now.

GET YOUR FREE Roundup CASE REVIEW TODAY

Roundup settlements are now being negotiated, but there is a limited window to pursue help. If you think you, a friend, or a family member may qualify, get your free case review today… before it’s too late!

  • * Submit now to learn if you may be eligible for a cash settlement or call (800) 511-3838 now.

Free Guide Download

The Step-By-Step Guide To Taking Action

How to File for Financial Settlement After Injury from an Unsafe Drug or Device

Free Guide Download

The Step-By-Step Guide To Taking Action

How to File for Financial Settlement After Injury from an Unsafe Drug or Device

LATEST ARTICLES

Why Post-Market Medical Device Follow-up is Necessary But Ignored or Hidden

As someone who’s had medical issues ranging from chronic pain to infertility, I’m no stranger to being poked, prodded, given a plethora of prescriptions, and feeling more like an alien abduction than a patient being presented solutions to feel better. Sound familiar?

Why Post-Market Medical Device Follow-up is Necessary But Ignored or Hidden

And why do we subjugate ourselves to being guinea pigs to test which therapies, pills, and mechanical parts will torment our bodies? It’s simple. We’re desperate for help and we trust the men and women in scrubs and suits to honestly want to help us. The FDA’s fast tracked 510(k) process,  doctors receiving “gifts” from pharmaceutical companies for prescribing their products, and sky high drug prices are just a few examples of the many parts of the system that are broken at the expense of patient health. Here’s another important flaw with the FDA and Big Pharma: their lack of post-market medical device follow-up.

But why should you take the time to learn about this? Consider these statistics:

  • In 2018, medtech (medical technology) stocks climbed 26%.
  • About 1.4 million hip and knee replacement surgeries were performed in 2017 alone and the number continues to increase each year.
  • The U.S. medical device market was $147.7 billion in 2016 and is projected to grow to $173 billion in 2019.

If you don’t already have a medical device, chances are high that you’ll either have one or you know someone who has one. Plus, this is big money for pharmaceutical companies so a variety of products are probably going to be advertised or recommended to you. Don’t you want to make sure that something this important is proven to help and not harm you?

The FDA’s 510(k) Approval and Post-Market Follow-up Process

The FDA established the 510(k) process to promote medical innovation and approve needed products to market quickly. However, this once “noble” function has now turned into a manipulation of Big Pharma to speed devices to market to for profit and to bypass expensive testing. The 510(k) process allows the FDA to fast-track paperwork through the system as pharmaceutical companies base their devices on previously approved ones… all without human clinical trials.

There are many problems to this practice. First of all, the products that they’re comparing the new one to may have been ineffective or harmful and taken off the market (such as the case involving Protegen transvaginal mesh). Secondly, this is how 70 percent of medical devices are being approved; again, WITHOUT human clinical trials. Is it any wonder why there are so many health complications and recalls concerning medical devices?!? Finally, the FDA is understaffed and underfunded which makes approving, monitoring, and following up on drugs and medical devices a nightmare.

Post market follow-up is critical to patient safety, as the FDA explains that the requirements, “include such things as tracking systems, reporting of device malfunctions, serious injuries or deaths, and registering the establishments where devices are produced or distributed. Postmarket requirements also include postmarket surveillance studies required under section 522 of the act as well as post-approval studies required at the time of approval of a premarket approval (PMA), humanitarian device exemption (HDE), or product development protocol (PDP) application.”

Let’s take a closer look at a recent example that hit the news in March 2019. Mentor Worldwide MemoryShape breast implants were approved in 2013. It came to the FDA’s attention that the company failed to enrol the required number of subjects in the post market study, had poor follow-up rates with patients (only 61 percent), and significant data wasn’t consistent.

These studies are particularly important because in 2016 it was determined that breast implants can cause breast implant-associated anaplastic large cell lymphoma, or BIA-ALCL, which is a type of non-Hodgkin’s lymphoma (cancer of the immune system). Post-market surveillance could not only ensure the safety of those in the study, but it can provide valuable information to prevent future patients from suffering from this disease.

Post-market surveillance is a critical part of the FDA’s job and public health depends on it. To quickly approve high risk medical devices and neglect monitoring how they work is not only negligent, but it deliberately disregards the health of the millions of patients that the FDA and pharmaceutical companies claim to be helping. It’s time to put patient health first.

 

##
Sources
“FDA warns J&J unit and Sientra over breast implant compliance”. Medical Device Network. Accessed March 25, 2019. https://www.medicaldevice-network.com/news/fda-warns-jj-sientra-breast-implants/
“Robots, DNA And Implantable Devices — Why 2019 Isn’t Your Dad’s Medtech”. Investor’s Business Daily. Accessed March 25, 2019. https://www.investors.com/news/technology/medical-equipment-medtech-2019-preview/
“Defenders: How medical devices are approved by the FDA and why some say it no longer works” KVUE. Accessed March 25, 2019. https://www.kvue.com/article/news/defenders-how-medical-devices-are-approved-by-the-fda-and-why-some-say-it-no-longer-works/269-2a9bfbe6-dd7d-4b2b-a0c1-6bebe24998cb
“Postmarket Requirements (Devices)”. FDA. Accessed April 2, 2019. https://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/PostmarketRequirements/default.htm
“Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL)”. FDA. Accessed April 2, 2019. https://www.fda.gov/MedicalDevices/ProductsandMedicalProcedures/ImplantsandProsthetics/BreastImplants/ucm239995.htm

Why Are There So Many Drug and Medical Device Recalls?

As an advocacy group that strives to keep the FDA and big pharmaceutical companies accountable, we’ve seen our share of hundreds of thousands of people angry, disillusioned, and scared because their medicine or medical device has been recalled. They trusted that their doctor or surgeon chose the best decision for their condition. They put their faith in the company that produced their drug or implant to monitor their materials for safety. The believed that the FDA would only approve products that were properly tested and proven safe. Now many of these patients are living in a new normal where they’re worried about whether their pills are safe or they’re in excruciating pain from an implant that can’t be removed. How can this happen? Why does it seem that drugs and medical devices are being recalled more than ever before?

Why Are There So Many Drug and Medical Device Recalls?

Reasons for Recalls

Drug and medical device recalls can either be required by the FDA based on reports they’ve been receiving or it can be voluntary on behalf of the company when their product(s) are potentially unsafe. Here are the main reasons for recalling a medical product:

  • Health Risks – If a medicine or implant is found to harm patients and causes a high potential for injury, then it could be recalled. For example, phenylpropanolamine (PPA), a drug that was used in decongestants and weight loss medicines, was recalled because it was found to increase the risk of hemorrhagic stroke (bleeding in the brain).
  • Poor labeling or packaging – If the dosing instructions are confusing, if the dosing device is faulty, or perhaps the packaging proves not to be childproof, then it could be recalled.
  • Mislabeled – Let’s say that you purchased a generic medication that was labeled gluten free but it in fact did contain gluten, then the company would have to rectify this error.
  • Compromised Manufacturing – This has been in the news a lot lately. Recently (January 2019) it was found that the popular blood pressure medication Valsartan was contaminated with N-nitrosodimethylamine, or NDMA, a possibly cancer-causing substance and an additional contaminant called nitrosodiethylamine, or NDEA.  

2018 – The Year of the Recall

Let’s look at some of the stats for 2018 from R&D Magazine to see how they were broken down into the above categories:

Pharmaceuticals (percentage of total drug recalls)

  • Failure to meet product specifications: 25%
  • Deviations from current Good Manufacturing Practice (cGMP): 23.9%
  • Sterility: 12%
  • Mislabeling: 10.9%
  • Foreign Materials: 7.6%

Medical Devices (number of recalls per cause)

  • Software issue: 79
  • Mislabeling issue: 43
  • Quality issue: 36
  • Sterility issue: 27

A Few of the Top Drug and Medical Device Recalls of 2018:

Other Important Facts to Know

  • Five companies reported ten or more recalls in the quarter. This is the highest number since Q3 2016 and the second highest since Q3 2013.
  • You can check the FDA’s website to see if your medication or implant has been recalled by clicking here.

Why Are There So Many Drug and Medical Device Recalls?

There are many reasons why the number of recalls are increasing. First of all, we’ve talked a lot about how the FDA and pharmaceutical companies fast-track medical devices to market without testing using the 510(k) process. Another problem is that many products and drugs are produced overseas (learn more here).  A third broken part in the system is that Big Pharma funds not only the FDA, but politicians who monitor this appendage of the government. An additional glitch is that the FDA is overworked and underfunded; they can’t keep up with all the applications, adverse effect reports, and follow-up documents causing many issues to fall into the cracks.

Clearly the FDA is broken at the cost of innocent patients and their health. It’s time we voice our concerns, educate ourselves about our health, and hold the FDA and Big Pharma accountable for harming millions of people.

 

##
Sources
“Drug Recalls Increased, Medical Device Recalls Decreased in Q3”. R&D Magazine. Accessed April 2, 2019. https://www.rdmag.com/news/2018/11/drug-recalls-increased-medical-device-recalls-decreased-q3
“What Is a Drug Recall?”. WebMD. Accessed April 2, 2019. https://www.webmd.com/a-to-z-guides/what-is-a-drug-recall#1

IVC Filter Use is Declining; What Does This Mean for Patients?

There are many drugs and medical devices that start out innocent enough: they are designed to help patients address difficult medical conditions and the benefits outweigh the risks in these specific situations. However, a common problem has occurred in which products become overused, over-marketed, and either used off-label or not according to manufacturer’s directions. This is certainly the case for IVC filters. Not only were they overused, but many times they were left in patients causing added risks to patient health.

IVC Filter Use is Declining; What Does This Mean for Patients?

Fortunately, a study published in the American Journal of Roentgenology found that IVC filter sales have dropped drastically over the past decade. “Between 2009 and 2015, IVC filter utilization across the United States declined by 36.3% in the Medicare population and by 26.6% in the privately insured population,” explained a statement from the Harvey L. Neiman Health Policy Institute.

This decline in sales is a win for patients due to the overuse and risks that these devices pose. IVC filters are prongs that form a tent-like structure to trap blood clots in the inferior vena cava, a large vein that carries blood to the heart. If a blood clot enters the heart or lungs, irreparable damage could take place.

IVC filters were supposed to be used in patients who were diagnosed with blood conditions that would be harmed from use of anticoagulants. “Filters should be considered for patients who cannot be anticoagulated and for those who fail anticoagulation for proximal DVT [deep vein thrombosis] or PE [pulmonary embolism],” states Akhilesh Sista, MD, FSIR, section chief and associate professor at New York University Langone School of Medicine.

IVC filters should only be used in these extreme circumstances due to the added risk they bring to patients. IVC filter prongs may break and migrate causing tissue damage and can even lodge in the heart. It has also been found that even though these medical devices have been labeled “retrievable” – meaning they should be removed after 29 to 54 days in most cases – many doctors fail to take these devices out of their patients putting them in danger.

Clearly the decline of IVC filter sales is a win for patients. These new statistics mean that doctors are carefully analyzing patient health verses the danger of using this device. If you have one of these medical devices or have an upcoming surgery which may involve an IVC filter, be sure to discuss any questions you may have with your doctor to ensure that this is the best option for your health.

 

##
Sources
“The decline of state-level IVC filter utilization”. EurekAlert!. Accessed April 8, 2019. https://www.eurekalert.org/pub_releases/2019-04/hlnh-tdo040419.php
“IVC filter overuse declining, but retrieval rates remain low”. Healio. Accessed April 8, 2019. https://www.healio.com/cardiac-vascular-intervention/venous/news/online/%7Bc384ddb8-e89b-4c26-9ee4-f514e48567da%7D/ivc-filter-overuse-declining-but-retrieval-rates-remain-low

Periscope Group is not owned by or operated on behalf of any attorney or law firm. We are not affiliated with any drug or medical device companies. We do not host advertisements nor do we accept advertising requests. We are here to help YOU, the consumer, become better educated and supported. You pay absolutely nothing for our help. It’s as simple as that.

Periscope Group is not owned by or operated on behalf of any attorney or law firm. We are not affiliated with any drug or medical device companies. We do not host advertisements nor do we accept advertising requests. We are here to help YOU, the consumer, become better educated and supported. You pay absolutely nothing for our help. It’s as simple as that.

HON Code Certification

© All Rights Reserved • 2017 • Periscope Group, 4155 Blackhawk Plaza Circle, Suite 100, Danville, CA 94506 Legal Disclaimer

Protected by Copyscape

© All Rights Reserved • 2017 • Periscope Group, 4155 Blackhawk Plaza Circle, Suite 100, Danville, CA 94506 Legal Disclaimer

HON Code Certification

Pin It on Pinterest